Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee

By F. Sacks, A. Lichtenstein, L. V. Van Horn, William S. Harris, P. Kris-Etherton, M. Winston. Circulation, 2006

657 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/4dba44cec043f3b7835fe0224a546c49cba114e3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. S. Daniels
2. S. Grundy

In Nutrition and Dietetics

1. S. Grundy

Citations in the corpus

• National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. (2015, methodology): “The AHA Soy Science Advisory Panel reported results from a meta-analysis that showed a mean LDL-C reduction of 3% with soy protein interventions from results in 22 randomized trials.(193) This panel also concluded that soy had no effect on HDL-C, TG, lipoprotein (a) [Lp(a)], or blood pressure.”
• Effect of high-fat diets supplemented with okara soybean by-product on lipid profiles of plasma, liver and faeces in Syrian hamsters (2011, background): “In a recent analysis of 22 randomised clinical trials, the findings showed a small decrease in LDL cholesterol by a soy protein supplement, but no change in cholesterol levels when isolated soy isoflavone was consumed by humans (Sacks et al., 2006).”